AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Ethinylestradiol

11 registrations across 2 African markets— 11 active

Markets with Ethinylestradiol

Recent registrations

Brand / ProductMarketHolderStatusExpires
CONTREZ🇿🇦South AfricaInnovata PharmaceuticalsactiveOct 2027
MINULETTE🇿🇦South AfricaPfizer Laboratories (Pty) LtdactiveJan 1900
NORDETTE*🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
MELODENE🇿🇦South AfricaBayer (Pty) Ltd û IsandoactiveJan 1900
EVRA🇿🇦South AfricaAcino Pharma (Pty) LtdactiveJan 1900
NUVARING🇿🇦South AfricaOrganon South Africa (Pty) LtdactiveJan 1900
NORDIOL🇿🇦South AfricaAKROMED PRODUCTS (PTY) LTDactiveJan 1900
LEVETTE🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
MENOFLUSH / MENOGLOED🇿🇦South AfricaPharmaceutical Enterprises (Pty) LtdactiveJan 1900
FEMODENE ED🇿🇦South AfricaBayer (Pty) Ltd û IsandoactiveJan 1900
Ethinylestradiol🌍WWQinhuangdao Zizhu Pharmaceutical Co Ltdactive

Ethinylestradiol in Africa — Regulatory Overview

Ethinylestradiol is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, WW. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.